India to Mauritius: Adalimumab Export Trade Route
India has recorded 10 verified shipments of Adalimumab exported to Mauritius, representing a combined trade value of $19.5K USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $2.0K USD. The leading Indian exporter is GENEX PHARMA, which accounts for 40% of total export value with 3 shipments worth $7.7K USD. On the buying side, TO THE ORDER OF is the largest importer in Mauritius with $7.7K USD in purchases. The top 3 suppliers — GENEX PHARMA, MEDICOS LIFESCIENCES, RELIANCE LIFE SCIENCES PRIVATE LIMITED — together control 80% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Mauritius Adalimumab corridor is one of India's established pharmaceutical export routes, with 10 shipments documented worth a combined $19.5K USD. The route is dominated by GENEX PHARMA, which alone accounts for roughly 40% of all export value, reflecting the consolidated nature of India's adalimumab manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $2.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with adalimumab's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 30.2%, placing it at rank #15 among India's top adalimumab export destinations globally.
On the import side, key buyers of Indian adalimumab in Mauritius include TO THE ORDER OF, FMT Mauritius Ltd, HYPERPHARM LTD. and 4 others. TO THE ORDER OF is the single largest importer with 3 shipments valued at $7.7K USD.
